Infectious diseases biobanking: Challenges and opportunities

NewsGuard 100/100 Score

This article is forms part of a special issue on "research on prevention and control of emerging infectious diseases" https://www.sciencedirect.com/journal/biosafety-and-health/vol/4/issue/4.

The COVID-19 pandemic has highlighted the practice of infectious diseases biobanking, as well as existing challenges and opportunities.

Governance frameworks allowing for the sharing of materials and data, the plurarity of sample collection and storing SOPs and the adherence to biosafety level requirements were highlighted as potential operational barriers.

The availability of an increased number of purpose-built biobanks with harmonized SOPs, allows for scalability of response in times of crisis.

Collaborations of infectious disease biobanks with existing vertical national and regional efforts provide synergistic opportunities that can positively impact biobank sustainability, staff training and retention.

Source:
Journal reference:

Matharoo-Ball, B., et al. (2022) Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks. Biosafety and Health. doi.org/10.1016/j.bsheal.2022.06.003.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged